Min Jung Lee is a pharmacist who is specialized in Oncology in Beverly Hills, California. Patients can reach her at 9090 Wilshire Blvd Ste 250, Beverly Hills or contact her on 310-967-7602. Active license number of Min Jung Lee is 85014 for Oncology in California. Min Jung Lee is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Min Jung Lee speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Min Jung Lee
Specialization:
Oncology
Credentials:
PHARMD
Gender:
Female
Location:
9090 Wilshire Blvd Ste 250, Beverly Hills, California, 90211-1848
Phone:
310-967-7602
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Min Jung Lee are as mentioned below.
NPI Number:
1952037632
NPI Enumeration Date:
26 Jul, 2022
NPI Last Update On:
26 Jul, 2022
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Min Jung Lee are as mentioned below.
Specialization
License Number
State
Status
Oncology
85014
California
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
13401 Riverside Dr Apt 303, Sherman Oaks, California
Zip:
91423-2599
Phone Number:
--
Fax Number:
--
Patients can reach Min Jung Lee at 9090 Wilshire Blvd Ste 250, Beverly Hills, California or can call on phone at 310-967-7602.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.